NASDAQ:NKTR - Nektar Therapeutics Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$32.17 -1.31 (-3.91 %)
(As of 03/22/2019 04:00 PM ET)
Previous Close$32.17
Today's Range$32.14 - $34.00
52-Week Range$29.22 - $108.23
Volume1.30 million shs
Average Volume1.88 million shs
Market Capitalization$5.60 billion
P/E Ratio8.51
Dividend YieldN/A

Analyst Ratings

Nektar Therapeutics (NASDAQ:NKTR) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
12 Wall Street analysts have issued ratings and price targets for Nektar Therapeutics in the last 12 months. Their average twelve-month price target is $76.9091, suggesting that the stock has a possible upside of 139.07%. The high price target for NKTR is $120.00 and the low price target for NKTR is $38.00. There are currently 2 hold ratings and 10 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.832.902.902.91
Ratings Breakdown: 0 Sell Rating(s)
2 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $76.9091$84.2222$86.6667$85.80
Price Target Upside: 139.07% upside102.02% upside134.42% upside44.52% upside

Nektar Therapeutics (NASDAQ:NKTR) Consensus Price Target History

Price Target History for Nektar Therapeutics (NASDAQ:NKTR)

Nektar Therapeutics (NASDAQ:NKTR) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/15/2019Svb LeerinkInitiated CoverageMkt Perform$38.00MediumView Rating Details
3/15/2019Leerink SwannInitiated CoverageMarket PerformHighView Rating Details
3/4/2019HC WainwrightReiterated RatingHold$47.00LowView Rating Details
3/1/2019Piper Jaffray CompaniesSet Price TargetBuy$100.00LowView Rating Details
3/1/2019MizuhoReiterated RatingBuy$81.00HighView Rating Details
2/22/2019BMO Capital MarketsInitiated CoverageOutperform$75.00MediumView Rating Details
12/13/2018Goldman Sachs GroupInitiated CoverageSell ➝ Buy$81.00 ➝ $62.00HighView Rating Details
11/13/2018Canaccord GenuityLower Price TargetBuy ➝ Buy$94.00 ➝ $86.00HighView Rating Details
11/8/2018CowenReiterated RatingBuy$86.00HighView Rating Details
11/8/2018Jefferies Financial GroupLower Price TargetBuy ➝ Buy$103.00 ➝ $73.00HighView Rating Details
8/9/2018William BlairReiterated RatingOutperformHighView Rating Details
6/4/2018JPMorgan Chase & Co.Lower Price TargetOverweight ➝ Overweight$90.00 ➝ $78.00HighView Rating Details
4/20/2018Seaport Global SecuritiesInitiated CoverageBuy$120.00LowView Rating Details
11/15/2017Canaccord Genuity GroupBoost Price TargetBuy$35.00 ➝ $50.00N/AView Rating Details
11/13/2017Roth CapitalSet Price TargetBuy$45.00N/AView Rating Details
8/17/2017Evercore ISIInitiated CoverageIn ➝ In-Line$20.00HighView Rating Details
5/10/2017AegisReiterated RatingBuy$27.00HighView Rating Details
(Data available from 3/23/2017 forward)
This page was last updated on 3/23/2019 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel